Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nym is a private healthcare technology company that uses artificial intelligence to automate medical coding for provider revenue cycle management. Its core product is an autonomous medical coding engine that interprets clinical language in patient charts and assigns billing codes with audit-ready traceability. The company markets its platform to health systems and physician groups across the United States, with support for multiple specialties including emergency medicine, radiology, outpatient surgery, and outpatient visits. Nym positions its technology as a way to reduce coding costs, accelerate time-to-bill, improve revenue capture, and ease administrative burden for healthcare organizations. The business is healthcare-related, but it is not a drug-development biotech or pharma company and does not appear to maintain a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nym Health.